The store will not work correctly when cookies are disabled.
5-Fluoro-3-methyl-N-[3-(1H-tetrazol-5-yl)phenyl]-1-benzothiophene-2-sulfonamide
ID: ALA3731503
PubChem CID: 56941309
Max Phase: Preclinical
Molecular Formula: C16H12FN5O2S2
Molecular Weight: 389.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c(S(=O)(=O)Nc2cccc(-c3nnn[nH]3)c2)sc2ccc(F)cc12
Standard InChI: InChI=1S/C16H12FN5O2S2/c1-9-13-8-11(17)5-6-14(13)25-16(9)26(23,24)20-12-4-2-3-10(7-12)15-18-21-22-19-15/h2-8,20H,1H3,(H,18,19,21,22)
Standard InChI Key: FVGLWSPCUSNJOM-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-0.4916 -3.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 1.3500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5524 -4.4208 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.7524 -4.4204 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1529 -5.4597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8028 -5.7210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5532 -7.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8059 -8.3214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5586 -9.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0586 -9.6159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8059 -8.3153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0533 -7.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3067 -8.3122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1709 -9.5226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5958 -9.0539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5904 -7.5539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1621 -7.0956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
8 10 1 0
10 11 2 0
11 2 1 0
11 5 1 0
3 12 1 0
12 13 2 0
12 14 2 0
12 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 389.44 | Molecular Weight (Monoisotopic): 389.0416 | AlogP: 3.33 | #Rotatable Bonds: 4 |
Polar Surface Area: 100.63 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.28 | CX Basic pKa: ┄ | CX LogP: 3.44 | CX LogD: 1.09 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.56 | Np Likeness Score: -2.34 |
References
1. (2012) New compounds, |
2. (2016) Sulfonamide compounds, |